Purple Biotech Analyst Ratings
Purple Biotech Analyst Ratings
While ratings are subjective and will change, the latest Purple Biotech (PPBT) rating was a maintained with a price target of $9.00 to $10.00. The current price Purple Biotech (PPBT) is trading at is $0.97, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/21/2023 | 933.7% | HC Wainwright & Co. | $9 → $10 | Maintains | Buy |
| 08/31/2023 | 830.33% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
| 08/30/2023 | 830.33% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
| 07/21/2023 | 726.96% | JonesTrading | → $8 | Initiates Coverage On | → Buy |
| 05/17/2023 | 623.59% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 05/17/2023 | 1037.07% | Chardan Capital | → $11 | Reiterates | Buy → Buy |
| 02/09/2023 | 623.59% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/09/2023 | 1037.07% | Chardan Capital | → $11 | Reiterates | → Buy |
| 10/17/2022 | 623.59% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 09/08/2022 | 1037.07% | Chardan Capital | → $11 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 11/21/2023 | 933.7% | HC Wainwright & Co. | 9 美元 → 10 美元 | 维护 | 买 |
| 08/31/2023 | 830.33% | HC Wainwright & Co. | 7 美元 → 9 美元 | 维护 | 买 |
| 08/30/2023 | 830.33% | HC Wainwright & Co. | 7 美元 → 9 美元 | 维护 | 买 |
| 07/21/2023 | 726.96% | JonesTrading | → 8 美元 | 启动覆盖范围开启 | → 购买 |
| 05/17/2023 | 623.59% | HC Wainwright & Co. | → 7 美元 | 重申 | 购买 → 购买 |
| 05/17/2023 | 1037.07% | 查丹资本 | → 11 美元 | 重申 | 购买 → 购买 |
| 02/09/2023 | 623.59% | HC Wainwright & Co. | → 7 美元 | 重申 | → 购买 |
| 02/09/2023 | 1037.07% | 查丹资本 | → 11 美元 | 重申 | → 购买 |
| 2022 年 10 月 17 日 | 623.59% | HC Wainwright & Co. | → 7 美元 | 启动覆盖范围开启 | → 购买 |
| 09/08/2022 | 1037.07% | 查丹资本 | → 11 美元 | 启动覆盖范围开启 | → 购买 |
What is the target price for Purple Biotech (PPBT)?
紫光生物科技（PPBT）的目标价格是多少？
The latest price target for Purple Biotech (NASDAQ: PPBT) was reported by HC Wainwright & Co. on November 21, 2023. The analyst firm set a price target for $10.00 expecting PPBT to rise to within 12 months (a possible 933.70% upside). 8 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年11月21日公布了紫色生物科技（纳斯达克股票代码：PPBT）的最新目标股价。该分析公司将目标股价定为10.00美元，预计PPBT将在12个月内升至12个月内（可能上涨933.70％）。去年有8家分析公司公布了评级。
What is the most recent analyst rating for Purple Biotech (PPBT)?
紫色生物科技（PPBT）的最新分析师评级是多少？
The latest analyst rating for Purple Biotech (NASDAQ: PPBT) was provided by HC Wainwright & Co., and Purple Biotech maintained their buy rating.
HC Wainwright & Co. 对紫色生物科技（纳斯达克股票代码：PPBT）的最新分析师评级由HC Wainwright & Co. 提供，紫色生物科技维持买入评级。
When is the next analyst rating going to be posted or updated for Purple Biotech (PPBT)?
Purple Biotech（PPBT）的下一次分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Purple Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Purple Biotech was filed on November 21, 2023 so you should expect the next rating to be made available sometime around November 21, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Purple Biotech的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Purple Biotech的最新评级是在2023年11月21日公布的，因此您应该预计下一个评级将在2024年11月21日左右公布。
Is the Analyst Rating Purple Biotech (PPBT) correct?
分析师评级紫色生物科技（PPBT）是否正确？
While ratings are subjective and will change, the latest Purple Biotech (PPBT) rating was a maintained with a price target of $9.00 to $10.00. The current price Purple Biotech (PPBT) is trading at is $0.97, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的紫色生物科技（PPBT）评级维持不变，目标股价为9.00美元至10.00美元。紫色生物科技（PPBT）目前的交易价格为0.97美元，超出了分析师的预期区间。